EPA, FDA Agreements Aim To Clear Up Burdensome Regulatory Environment
This article was originally published in The Gray Sheet
Executive Summary
Complex, overlapping federal regulations potentially are blocking availability of innovative disinfectants for medical uses, speakers at a recent Food & Drug Law Institute meeting suggested